← Pharmacy Technicians CPD

Alternative Antibiotics: 2nd Gen. Cephalosporins

This CPD event is currently available to enroll in. It will be a LIVE ONLINE SESSION with an interactive component. This course will then be hosted on this platform as a pre-recorded training, allowing participants to engage further with the material and ask questions outside the live session.

In response to the evolving landscape of antimicrobial resistance (AMR) and the need for diversified therapeutic approaches, Continuous Education Services (CES) is delighted to announce a collaborative effort with Kofikrom Pharmacy to present a virtual Continuing Professional Development (CPD) training session titled "Alternative Antibiotics: 2nd Gen. Cephalosporins."


By participating in, and achieving the objectives of this training, participants will be equipped with the knowledge and confidence to integrate 2nd Gen Cephalosporins into their clinical practices effectively. This CPD training not only contributes to the continuous professional development of healthcare practitioners but also aligns with the broader goal of addressing the challenges posed by antimicrobial resistance.


We look forward to the opportunity to collaborate on this educational initiative and contribute to the success of Kofikrom Pharmacy's efforts in promoting the appropriate use of cephalosporin antibiotics.



1. Identify current available alternative antibiotics (2nd Gen Cephalosporins)

i. Explore the spectrum of 2nd Gen Cephalosporins available in the market.

ii. Understand the unique characteristics and advantages of each antibiotic within this class.


2. Evaluate the therapeutic outcomes of use

i. Examine clinical case studies highlighting successful outcomes with 2nd Gen Cephalosporins.

ii. Discuss the appropriate scenarios for prescribing these antibiotics based on patient profiles.


3. Review the prevalence and persistence of AMR:

i. Gain insights into the global prevalence of antimicrobial resistance.

ii. Understand the role of 2nd Gen Cephalosporins in combating AMR and promoting responsible antibiotic use.


Target Audience: Physicians and General Practitioners, Pharmacists, Clinical Care Staff

Moderator: Papa Yaw Agyekum Addo (Superintendent Pharmacist, Kofikrom Pharmacy Ltd.)

Time and Date: Premieres at 1000 GMT (10:00 am local time) on Monday the 27th of November 2023 (VIRTUAL EVENT) 



3:50 - 4:00 pm: Welcome

4:00 - 4:05 pm: Introduction by Papa Yaw Agyekum Addo

4:05 - 4:35 pm: Presentation Case Discussion by Dr. Marc Dzradosi

4:35 - 4:50 pm: Product Presentation by Papa Yaw Agyekum Addo

5:10 - 5:40 pm: Question and Answer Session Dr. Marc Dzradosi and Papa Yaw Agyekum Addo

5:40 - 5:55 pm: Key Takeaways and Closing - All





This is a virtual event that will premiere on Monday the 27th of November 2023 at 10:00 am. The event will be streamed live on this page.



In the realm of pharmaceutical innovation and commitment, Kofikrom Pharmacy Limited (KKPL) emerges as a dynamic force, embodying the ethos of excellence and dedication. Founded by the visionary Pharmacist Kofi Addo-Agyekum, acknowledged as the 2022 CEO of the Year (Pharmaceutical) by the Ghana West Africa Healthcare Excellence Awards, KKPL is at the forefront of providing top-tier pharmaceutical products and services.

Vision and Mission: KKPL aims to be a global healthcare leader, dedicated to promoting good health through the production, distribution, and sale of quality, affordable, and accessible pharmaceutical and medical products and services. This vision drives a mission that reflects a commitment to professionalism, integrity, and leadership in healthcare worldwide.

Product Excellence: KKPL takes pride in its extensive product range, encompassing proprietary medicines, UK generics, locally manufactured branded and generic medicines, as well as medical disposables and equipment. The Kwality Kare range, locally manufactured for quality, efficacy, and affordability, stands as a testament to KKPL's commitment to providing accessible healthcare solutions.

Divisions and Expertise: Established in 2015, KKPL has rapidly expanded, boasting over 75 Ghana FDA-registered branded generics. The company operates seamlessly through three divisions – Manufacturing, Retailing, and Wholesale & Distribution. Each division is fuelled by a team of seasoned professionals, ensuring a wealth of experience and expertise in the pharmaceutical industry.

Awards and Recognition: KKPL's pursuit of excellence has been acknowledged through various awards and accolades, underscoring its dedication to quality and innovation. In a relatively short span, KKPL has earned a well-deserved reputation as a formidable player in the pharmaceutical arena.

Customer-Centric Approach: KKPL places a premium on customer satisfaction, with a well-trained staff committed to delivering outstanding customer service. This commitment is woven into the fabric of every operation, ensuring that clients receive not only products of the highest quality but also service excellence.

As KKPL continues to evolve and make significant strides in the pharmaceutical industry, its mission aligns with our own at Continuous Education Services (CES) – a commitment to the well-being of communities through the provision of high-quality healthcare solutions.


Kofikrom Pharmacy Limited – A Centre of Leadership in Healthcare Worldwide


Course Description

This collaborative training aims to address the underutilization of cephalosporin antibiotics, specifically those belonging to the second generation, in clinical practices. Recognizing the importance of raising awareness among healthcare professionals to enhance their understanding of the therapeutic potential of these antibiotics, Kofikrom Pharmacy and CES have joined forces to organize this accredited CPD training. Our shared objective is to provide valuable insights that improve therapeutic outcomes.

What you will learn

It is anticipated that, upon the completion of the training, participants will acquire a comprehensive understanding and knowledge in the following areas:

1. Identification of Current Alternative Antibiotics (2nd Gen Cephalosporins).
2. Evaluation of Therapeutic Outcomes.
3. Review of Antimicrobial Resistance (AMR) Prevalence and Persistence.

Coming Soon

Course Content

Lecture Sessions

  • PRE-RECORDED EVENT: Premiering on Monday 27th November 2023 @ 1000 GMT (10:00 am) 1 hour


No downloadable content added to this course yet.

Steps to Join Course

  • 1. Register or Login
  • 2. Confirm your email address by clicking a link from your email
  • 3. Choose course under your profession
  • 4. Click on Get Free Course
  • 5. Find your new course under My Courses
  • 6. Click on course to see contents
  • 7. Complete all Sessions and Quizes
  • 8. Download your Certificate

About Facilitator

  • 8 Courses on CES

Dr. Marc Kwame Dzradosi

Pharm.D, FGCPharm, MPSGh.

Clinical Pharmacy Specialist / Lecturer

Head of Pharmaceutical Services – International Maritime Hospital.

Dr Marc K. Dzradosi has over fifteen (15) years’ experience in Hospital based Clinical Pharmacy Services, Academia, Research, Healthcare Administration, Public Health, Nutrition, and Exercise Science.

View full profile / courses